Myasthenia Gravis

Neurology

Autoimmune disorder of NMJ acetylcholine receptors causing fatigable weakness, ptosis, diplopia.

History taking

  • • Onset, duration, progression, severity
  • • Aggravating / relieving factors
  • • Past history, drugs, allergies, comorbidities
  • • Family & social history relevant to presentation

Examination

  • • General: vitals, pallor, icterus, oedema, lymphadenopathy
  • • Focused system examination
  • • Look for red-flag findings

Red flags

  • • Myasthenic crisis: respiratory failure → ICU

Differential diagnosis

  • • See differentials section per chief complaint

Recommended investigations

  • • Anti-AChR, anti-MuSK antibodies
  • • Repetitive nerve stimulation / single-fibre EMG
  • • CT chest for thymoma

Diagnosis

  • • Clinical diagnosis supported by targeted investigations

Initial treatment / management

  • • Treat underlying cause
  • • Symptomatic relief
  • • Patient education

Drug therapy

  • • Pyridostigmine 30–60 mg QDS
  • • Prednisolone + steroid-sparing (azathioprine / MMF)

Follow-up advice

  • • Review in 2–4 weeks or earlier if worsening
  • • Monitor response to therapy and adverse effects

Patient counselling

  • • Explain diagnosis and natural course in lay terms
  • • Red-flag symptoms warranting urgent return
  • • Adherence to medications and follow-up

Referral criteria

  • • Refer if diagnostic uncertainty, complications, or failure of first-line therapy

References

  • • Harrison's Principles of Internal Medicine, 21e
  • • NICE / WHO guidelines (current edition)

Educational outpatient guide — verify against local guidelines before clinical use.

WardRound

WardRound

Clinical Decisions in Seconds